27EC Trabulsi, Edouard - Thomas Jefferson University - Thomas Jefferson University
ext273

Edouard Trabulsi, MD

Contact Dr. Trabulsi

1025 Walnut Street
Suite 1112
Philadelphia, PA 19107

(215) 955-6961
(215) 923-1884 fax

Most Recent Peer-reviewed Publications

  1. Genomic prostate cancer classifier predicts biochemical failure and metastases in patients after postoperative radiation therapy
  2. Surgical suturing training with virtual reality simulation versus dry lab practice: an evaluation of performance improvement, content, and face validity
  3. Impact of NADiA ProsVue PSA slope on secondary treatment decisions after radical prostatectomy
  4. The effects of fatigue on robotic surgical skill training in Urology residents
  5. High dose rate brachytherapy boost for prostate cancer: A systematic review
  6. A paradigm shift from anatomic to functional and molecular imaging in the detection of recurrent prostate cancer
  7. Patterns of care for elderly men diagnosed with favorable-risk prostate cancer from 2004 to 2008 : A population-based analysis
  8. Identifying barriers to patient acceptance of active surveillance: content analysis of online patient communications.
  9. Targeting cell cycle and hormone receptor pathways in cancer
  10. Pharmacologic inhibition of Jak2-Stat5 signaling by Jak2 inhibitor AZD1480 potently suppresses growth of both primary and castrate-resistant prostate cancer
  11. Evolution of advanced technologies in prostate cancer radiotherapy
  12. Percutaneous cryoablation for recurrent low grade renal cell carcinoma after failed nephron-sparing surgery
  13. STAT5A/B gene locus undergoes amplification during human prostate cancer progression
  14. The dilemma of a rising prostate-specific antigen level after local therapy: What are our options?
  15. Multimodality therapy for patients with high-risk prostate cancer: Current status and future directions
  16. Salvage radiotherapy for prostate cancer: Finding a way forward using radiobiological modeling
  17. Diagnostic performance of PCA3 to detect prostate cancer in men with increased prostate specific antigen: A prospective study of 1,962 cases
  18. Contrast enhanced transrectal ultrasound for the detection of prostate cancer: A randomized, double-blind trial of dutasteride pretreatment
  19. Prognostic factors and outcomes after definitive treatment of female urethral cancer: A population-based analysis
  20. Value 0150 of contrast-enhanced ultrasonography in prostate cancer
0